Sigilon Therapeutics, Inc. (45) | Human Resources (12)

Browse by Subcategory

Recent Contracts

Consulting Agreement, dated October 13, 2021, between the Company and May Orfali, M.D (Filed With SEC on March 14, 2022)
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on November 30, 2020)
Severance Waiver and Offer Letter Amendment, between Sigilon Therapeutics, Inc. and Rogerio Vivaldi Coelho, M.D., dated October 26, 2020 (Filed With SEC on November 13, 2020)
Sigilon Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy (Filed With SEC on November 13, 2020)
Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 13, 2020)
Consulting Agreement between Sigilon Therapeutics, Inc. and Devyn Smith, dated April 26, 2021 (Filed With SEC on August 10, 2021)
Form of Incentive Stock Option Agreement (Filed With SEC on November 30, 2020)
Sigilon Therapeutics, Inc. 2016 Stock Option and Grant Equity Incentive Plan, as amended (Filed With SEC on November 13, 2020)
Form of Incentive Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on November 13, 2020)
Form of Nonstatutory Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan (Filed With SEC on November 13, 2020)
Form of Non-Chief Executive Officer Severance Waiver and Offer Letter Amendment (Filed With SEC on November 13, 2020)
Sigilon Therapeutics, Inc. 2020 Cash Incentive Plan (Filed With SEC on November 13, 2020)